A patch for treating menopause that the manufacturer calls the smallest is now available.
Mylan will begin selling a generic drug for treating symptoms of menopause in two years, the company said Monday.
A group of drug makers have sued Mylan over its attempt to gain Food and Drug Administration approval for a generic menopause drug, Mylan said Tuesday.